thiazolidines has been researched along with Hypoglycemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (92.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Haneda, M; Ito, H; Kadowaki, T; Sasaki, K; Yamada, Y | 1 |
| Gouda, M; Iijima, H; Inagaki, N; Kadowaki, T; Kaneko, G; Kondo, K; Maruyama, N; Nakanishi, N; Nishimura, K; Watanabe, Y | 2 |
| Haneda, M; Iijima, H; Ito, H; Kadowaki, T; Kimura, M; Matsukawa, M; Sasaki, K; Ueno, M; Yamakura, T | 1 |
| Haneda, M; Hiraide, S; Ito, H; Kadowaki, T; Matsukawa, M; Sasaki, K; Ueno, M | 1 |
| Fujii, M; Iida, Y; Kanasaki, K; Kitada, M; Konishi, K; Koya, D; Nakagawa, A; Nitta, K; Ogura, Y | 1 |
| Kadowaki, T; Kondo, K | 1 |
| Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T | 1 |
| Nakamura, S; Nakazato, M; Sakoda, H; Tsubouchi, C; Tsuchimochi, W; Ueno, H; Yamashita, E | 1 |
| Morishita, R; Nakagami, H | 1 |
| Iijima, H; Kadowaki, T; Katoh, M; Marubayashi, F; Yokota, S | 1 |
| Ahn, CW; Cho, YW; Chung, CH; Han, KA; Hong, S; Jang, HC; Ku, BJ; Lee, CB; Lee, MK; Moon, MK; Park, CY; Park, SW; Son, HS | 1 |
| Bryson, A; Deak, L; Jennings, PE; Lawson, M; Paveliu, FS | 1 |
| Emoto, N; Hattori, N; Nagamine, T; Nakamura, Y; Okajima, F; Sugihara, H | 1 |
2 review(s) available for thiazolidines and Hypoglycemia
| Article | Year |
|---|---|
Teneligliptin : expectations for its pleiotropic action.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Pyrazoles; Thiazolidines | 2015 |
Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.
Topics: Asian People; Blood Glucose; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Pyrazoles; Thiazolidines | 2015 |
5 trial(s) available for thiazolidines and Hypoglycemia
| Article | Year |
|---|---|
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
Topics: Aged; Canagliflozin; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Exercise; Female; Humans; Hyperglycemia; Hypoglycemia; Japan; Male; Membrane Transport Modulators; Middle Aged; Pyrazoles; Sodium-Glucose Transporter 2; Thiazolidines | 2018 |
Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension.
Topics: Adult; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Postprandial Period; Pyrazoles; Sulfonylurea Compounds; Thiazolidines; Treatment Outcome | 2014 |
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial.
Topics: Administration, Oral; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exercise; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Incidence; Insulin Resistance; Patient Compliance; Pyrazoles; Republic of Korea; Thiazolidines; Time Factors | 2016 |
The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pyrazoles; Thiazolidines; Treatment Outcome | 2016 |
Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines; Thiophenes; Treatment Outcome; Young Adult | 2017 |
7 other study(ies) available for thiazolidines and Hypoglycemia
| Article | Year |
|---|---|
Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan.
Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Product Surveillance, Postmarketing; Pyrazoles; Thiazolidines | 2020 |
Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
Topics: Aged; Anti-Obesity Agents; Body Mass Index; Canagliflozin; Cohort Studies; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Therapy, Combination; Exercise; Female; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Membrane Transport Modulators; Middle Aged; Overweight; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines | 2018 |
Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Chemical and Drug Induced Liver Injury; Constipation; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Product Surveillance, Postmarketing; Pyrazoles; Surveys and Questionnaires; Thiazolidines | 2018 |
Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.
Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Healthy; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Pyrazoles; Thiazolidines | 2018 |
Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.
Topics: Aged; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemia; Incidence; Japan; Male; Prognosis; Prospective Studies; Pyrazoles; Thiazolidines | 2019 |
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines | 2014 |
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Japan; Middle Aged; Monitoring, Ambulatory; Postprandial Period; Pyrazoles; Thiazolidines | 2015 |